IGF-1 Signaling in the Formation of Three-Dimensional Laminated Neural Retina and Ocular Structures From Human Embryonic Stem Cells
Source Mellough et al., 2015 · Institute of Genetic Medicine, Newcastle University · 10.1002/stem.2023
Abstract
A protocol for differentiating human embryonic stem cells (hESCs) into three-dimensional laminated neural retina with photoreceptor cells displaying advanced maturation features including inner and outer segment-like structures and phototransduction capacity by 6.5 weeks of differentiation. The protocol employs IGF-1 supplementation in minimal serum-free media and also generates accessory ocular structures including retinal pigmented epithelium, lens, and corneal-like epithelium.
Protocol overview
24 steps across 7 phases
- 1 hESC Expansion and Embryoid Body Formation
- 2 Ventral Neural Induction Media Supplementation
- 3 Time-Lapse Morphological Documentation
- 4 Transition to Basal Knockout Serum-Free Media with IGF-1 Continuation
- 5 Extended Maturation Culture
- 6 Media Changes
- 7 Embryoid Body Fixation
- 8 Cryostat Sectioning
- 9 Immunocytochemical Staining
- 10 Microscopy and Image Acquisition
- 11 Tissue Preparation for Electron Microscopy
- 12 TEM Imaging and Analysis
- 13 Embryoid Body Dark Adaptation
- 14 Fura-2-AM Loading
- 15 Perfusion with Oxygenated Artificial Cerebrospinal Fluid (aCSF)
- 16 cGMP Stimulation and Control Recordings
- 17 Calcium Imaging Acquisition
- 18 Fluorescence Data Analysis
- 19 Confirmation of Photoreceptor Identity by Immunocytochemistry
- 20 IGF-IR Inhibition Experiments
- 21 IGF-IIR Neutralization Experiments
- 22 Optic Vesicle and Cup Counting
- 23 Data Collection and Presentation
- 24 Statistical Significance Testing
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Mellough et al., 2015. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol